Literature DB >> 2247117

Congenital absence of the vas deferens. The fertilizing capacity of human epididymal sperm.

S J Silber1, T Ord, J Balmaceda, P Patrizio, R H Asch.   

Abstract

BACKGROUND: Congenital absence of the vas deferens has been considered a virtually untreatable cause of male sterility. Furthermore, sperm that have not passed through at least the head of the epididymis have been thought to be incapable of causing pregnancy. We attempted to determine whether human sperm that had never passed through the epididymis could fertilize eggs in vitro and whether the technique could be used for men with congenital absence of the vas deferens.
METHODS: Twenty-eight men with congenital absence of the vas deferens underwent microsurgical aspiration of sperm from the epididymis and vasa efferentia for attempted in vitro fertilization of their wives' oocytes, with subsequent transfer of embryos. Thirty-two treatment cycles were begun (four were repeat cycles).
RESULTS: The most motile sperm were found in the proximal epididymis, at or near the vasa efferentia. Embryos were obtained for transfer in 21 cases (66 percent). Ninety-three embryos resulted from 352 mature oocytes (fertilization rate, 26 percent). Clinical pregnancy was achieved in 10 of the 32 treatment cycles (31 percent). Seven women delivered normal infants, and three miscarried. One of the seven live births was of twins. There were six girls and two boys. When fewer than 10 eggs were retrieved, no pregnancy occurred. When 10 or more eggs were retrieved (20 cases), the pregnancy rate was 50 percent.
CONCLUSIONS: Sperm from the proximal caput epididymidis and even sperm from the vasa efferentia (which have never passed through the epididymis) can fertilize the human oocyte in vitro and result in pregnancy with live birth.

Entities:  

Mesh:

Year:  1990        PMID: 2247117     DOI: 10.1056/NEJM199012273232602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  26 in total

1.  A simplified method for processing sperm obtained during microsurgical epididymal sperm aspiration (MESA) for use in in vitro fertilization.

Authors:  A K Dubey; R D Oates; V R Cardone; N A Harrington; D R McInnes
Journal:  J Assist Reprod Genet       Date:  1992-12       Impact factor: 3.412

2.  Efficacy of microsurgical epididymal sperm aspiration (MESA) and intracytoplasmic sperm injection (ICSI) in obstructive azoospermia.

Authors:  I P Son; J Y Hong; Y S Lee; Y S Park; J H Jun; H J Lee; I S Kang; J Y Jun
Journal:  J Assist Reprod Genet       Date:  1996-01       Impact factor: 3.412

3.  Microinsemination techniques for the treatment of patients suffering agenesia of the vas deferens.

Authors:  L Gianaroli; M C Magli; G Colpi; G Vitali; D Fortini; L Negri; A P Ferraretti
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

4.  Reproductive and sexual health in adolescents with cystic fibrosis.

Authors:  S M Sawyer
Journal:  BMJ       Date:  1996-11-02

Review 5.  A managed care provider's approach toward mandated infertility coverage: the Illinois Family Building Act.

Authors:  D Pratt; B F Vanderlaan; A Dudkiewicz; V Karande; A L Widen
Journal:  J Assist Reprod Genet       Date:  1994-10       Impact factor: 3.412

6.  Minimally invasive surgery for male subfertility.

Authors:  Y Khalifa; J G Grudzinskas
Journal:  BMJ       Date:  1996-01-06

Review 7.  Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.

Authors:  D A S de Souza; F R Faucz; L Pereira-Ferrari; V S Sotomaior; S Raskin
Journal:  Andrology       Date:  2017-12-07       Impact factor: 3.842

8.  Compound heterozygosity for the delta F508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens.

Authors:  D Meschede; A Eigel; J Horst; E Nieschlag
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

9.  Counseling and screening for cystic fibrosis in patients with congenital bilateral absence of the vas deferens: Patient perceptions.

Authors:  J L Fitzpatrick; E M Hutton; R Babul; C S Cytrynbaum; J E Sutherland; C T Shuman
Journal:  J Genet Couns       Date:  1996-03       Impact factor: 2.537

Review 10.  Male contraception.

Authors:  John K Amory
Journal:  Fertil Steril       Date:  2016-09-24       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.